← All reports

Metformin administered during acute COVID-19 infection reduces the risk of long COVID by 50%.

HealthcareScienceJun 12, 2026score 0.902 posts · 4 replies across 2 instances
A study published in 2026 suggests that metformin, when administered during acute COVID-19 infection, reduces the risk of long COVID by 50%. The findings are reported by multiple sources, including EurekAlert and MedicalXpress, with links to the full paper and additional coverage.

Claims

Metformin administered during acute COVID-19 infection reduces the risk of long COVID by 50%.
Parent: HealthcareEntity: MetforminSub-entity: Long COVID treatmentImpact: positiveDate: Jun 12, 2026 - Jun 13, 2026Target: Metformin's effectiveness in reducing long COVID risk

Source posts

@[email protected]
"New study shows metformin given during acute COVID-19 infection reduced risk of clinician-diagnosed long COVID by 50%" "At 6 months, participants who received metformin experienced a 50% relative reduction in the risk of clinician-diagnosed long COVID compared with those receiving placebo" Source: https://medicalxpress.com/news/2026-06-metformin-acute-covid-infection-clinician.html Study: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciag335/8702406
37 boosts · 31 favs · 4 replies · Jun 13, 2026
@[email protected]
News Release 11-Jun-2026 New study shows metformin given during acute COVID-19 infection reduced risk of clinician-diagnosed long COVID by 50% https://www.eurekalert.org/news-releases/1131805 Full paper: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciag335/8702406 Hashtags: @longcovid #LongCovid #PASC #PwLC #postcovid #postcovid19 #PostCovidSyndrome #LC #Covidlonghaulers #longhaulers #COVIDBrain #NeuroPASC #Coronavirus #COVID19 #COVID #COVID_19 #COVIDー19 #SARSCoV2 #auscovid19 #CovidIsNotOver @novid #novid
5 boosts · 0 favs · 1 replies · Jun 12, 2026
#longcovid#pasc#pwlc#postcovid#postcovid19#postcovidsyndrome